GTC Biotherapeutics (fka GTCB)

[Beerzoids]

Dew, you posted: "Importantly, Ovation will pay for all US-related clinical development of ATryn from this point forward (except as noted in #5 below)." ===

How will this reduce GTCB's cash burn rate going forward? How much of current "ongoing" expenditures might be effected by this deal?

Taking over costs, is just as good as milestone payments.